InvestorsHub Logo

Biobillionair

08/01/19 9:41 PM

#205157 RE: sstyles #205154

Ss-Let’s be clear here

JT drops several gems. He said, "[w]hen we come together next quarter, we believe we will have received FDA approval of our expanded indication for Vascepa, and we look forward to sharing even more about the progress we're making to introduce a new era in cardiovascular health." Given JT's conservative nature, you do not make this comment unless you are certain FDA approval is imminent”



IF Amarin has another quarterly CC...

After label expansion I think it will be impossible for Amarin to dodge a public admission of an M&A offer.

BB